Compounds useful as faah modulators and uses thereof
OwnerMatthew Duncton, Donogh John Roger O'mahony +1inventors
InventorsMatthew Duncton, Donogh John Roger O'mahony, Matthew Cox
Life of this patent
Estimating the term…
Abstract
Compounds are disclosed that have formula I: where A, B, L1, W, Y, R1, and R3 are as defined herein. The compounds and pharmaceutical compositions thereof are useful for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, pain, anxiety, depression, inflammation, cognitive disorders, weight and eating disorders, Parkinson's disease, Alzheimer's disease, spasticity, addiction, glaucoma, and others.
Claims73
A compound having a formula:
- wherein
- each A and B is independently CR2aR2b;
- W and Z are independently N or CR4;
- L1 is a single bond or substituted or unsubstituted C1-C5 alkylene, —CO—, —NHC(O)—, —OC(O)—, —SO—, or S(O)2—;
- R1 is selected from a substituted or unsubstituted aryl or heteroaryl;
- each of R2a, and R2b is independently selected from hydrogen, and substituted or unsubstituted C1-C6 alkyl;
- R3 is selected from substituted or unsubstituted C1-C6alkyl, substituted or unsubstituted C3-C8cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, and substituted or unsubstituted heteroaryl;
- and
- R4 is independently selected from H, C1-C6alkyl, substituted C1-C6alkyl, acyl, substituted acyl, substituted or unsubstituted acylamino, substituted or unsubstituted amino, substituted or unsubstituted alkoxy, alkoxycarbonyl, substituted alkoxycarbonyl arylalkyloxy, substituted arylalkyloxy, amino, aryl, substituted aryl, arylalkyl, substituted arylalkyl, substituted sulfanyl, substituted sulfinyl, substituted sulfonyl, substituted or unsubstituted aminosulfonyl, sulfo, sulfonic acid ester, azido, carboxy, substituted or unsubstituted carbamoyl, cyano, substituted or unsubstituted C3-C8cycloalkyl, substituted or unsubstituted heterocycloalkyl, halo, heteroaryloxy, substituted or unsubstituted heteroaryl, hydroxy, nitro, and thiol;
- or a pharmaceutically acceptable salt, solvate or prodrug thereof;
- and stereoisomers, isotopic variants and tautomers thereof;
- provided that the compound is other than
- N-[5-(1,1-dimethylethyl)-2-methylphenyl]-6,7-dihydro-2-[4-(4-methoxyphenyl)-1-piperazinyl]-6-(methylsulfonyl)-5H-pyrrolo[3,4-d]pyrimidin-4-amine;
- 4-[[5-(1,1-dimethylethyl)-2-methylphenyl]amino]-5,7-dihydro-2-[4-(4-methoxyphenyl)-1-piperazinyl]-6H-Pyrrolo[3,4-d]pyrimidine-6-carboxylic acid, 1,1-dimethylethyl ester;
- 2-chloro-4-[[3-(dimethylamino)-5-methoxyphenyl]amino]-5,7-dihydro-6H-pyrrolo[3,4-d]pyrimidine-6-carboxylic acid, 9H-fluoren-9-ylmethyl ester;
- 2-chloro-5,7-dihydro-4-[(5-methyl-1H-pyrazol-3-yl)amino]-6H-pyrrolo[3,4-d]pyrimidine-6-carboxylic acid, 9H-fluoren-9-ylmethyl ester;
- and
- N-(2,3-dihydro-1H-inden-2-yl)-6,7-dihydro-2-(methylthio)-6-(phenylmethyl)-5H-pyrrolo[3,4-d]pyrimidin-4-amine.
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
Dependencies are inferred from the claim text.